The startup develops a health technology platform that utilizes proprietary surveillance tools and predictive models to analyze infectious diseases, including COVID-19 and RSV. This platform enables pharmaceuticals, governments, and investors to access real-time health intelligence, facilitating rapid decision-making to enhance public health responses.
Funding
$9.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Pharmaceutical companies, governments, and investors often lack real-time insights into infectious disease dynamics, hindering their ability to make informed decisions regarding public health responses, resource allocation, and investment strategies. Traditional methods of disease surveillance and analysis are often slow, fragmented, and lack predictive capabilities. This can lead to delayed interventions, inefficient resource utilization, and suboptimal health outcomes.
Solution
Airfinity provides a predictive health intelligence platform that tracks, simulates, and forecasts population-level disease outcomes in real time. The platform aggregates and analyzes data from diverse sources to deliver comprehensive insights into emerging outbreaks, disease prevalence, and the impact of medical interventions. By combining advanced meta-science, statistics, epidemiology, and machine learning, Airfinity's models provide actionable intelligence for proactive decision-making. The platform supports horizon scanning, medical countermeasure impact modeling, clinical trial site optimization, and scenario-based demand intelligence.
Target Audience
Airfinity's primary customers include pharmaceutical companies, biotech firms, government health agencies, healthcare authorities, and investment firms seeking to make data-driven decisions in response to infectious diseases and other health threats.
Features
- Real-time surveillance of over 160 infectious diseases with Airfinity Biorisk, providing alerts and analysis on emerging outbreaks and infectious disease risks
- Airfinity One ID delivers infectious disease intelligence and forecasting, offering real-time analysis for over 160 diseases
- Dynamic disease forecasting models support horizon scanning and medical countermeasure impact modeling
- Global Outbreaks Tracker dashboard displays the largest global infectious disease outbreaks with risk assessments
- Emergent Risk Models investigate the risk of variants and strains of pathogens of concern
- Predictive indicators on trial read out timelines, approval likelihoods, and standard of care inclusion
- The Obesity Market Intelligence Solution provides analysis and forecasts on the clinical, commercial, and epidemiological landscapes
- CVRM Intelligence and Forecasting delivers tailor-made solutions for cardiovascular, renal, and metabolic healthcare sectors